For the last 20 years, Dr. Steinbach has led an NIH-funded multidisciplinary clinical care and research program supporting immunosuppressed children. His molecular, translational, and clinical research focuses on the pathogenesis, diagnosis and treatment of invasive fungal infections and spans broader efforts with all infections in immunocompromised patients. His laboratory centers on the fungus Aspergillus fumigatus to understand the molecular mechanisms of cellular signal transduction in disease, develop novel fungal-specific molecular targets as therapeutics, devise new diagnostic assays, and conduct phase I-IV clinical trials in children.

Dr. Steinbach founded and is the Director of the International Pediatric Fungal Network, a global consortium of 55 sites dedicated to investigating pediatric invasive fungal infections through multi-center cooperative studies that have led to the first pediatric-specific guidelines for these diseases. He also co-founded and co-Chairs the biennial (2004-2022 to date) international Advances Against Aspergillosis conference. He has co-edited four textbooks, including Aspergillus fumigatus and Aspergillosis, Feigin & Cherry's Textbook of Pediatric Infectious Diseases, the American Academy of Pediatrics Nelson's Pediatric Antimicrobial Therapy, and most recently, the first textbook in a new subfield: Pediatric Transplant and Oncology Infectious Diseases.

Medical Degree

  • University of North Carolina at Chapel Hill - 1998

Residency

  • Stanford University - 2001

Fellowship

  • Duke University Medical Center - 2004

Related Services

Related News

Related Blogs